To study the determinants of neonatal survival and outcome of preterm deliveries at the Department of Obstetrics and Gynaecology, University of Maiduguri Teaching Hospital, Maiduguri, Nigeria.
Introduction
Preterm delivery (PTD) is the leading cause of perinatal morbidity and mortality worldwide with 1.1 million infant deaths due to complications of prematurity in 2010. [1] Developing countries including Nigeria contribute more than 60% of the world's preterm babies and over 80% of global preterm deaths. [1, 2] The double misfortune of high PTD and low neonatal survival in these areas may be because of poor antenatal care, malaria, and other infectious causes Determinants of neonatal survival following preterm delivery at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria of PTD [3] [4] [5] coupled with the lack of access to the expensive treatments such as surfactant needed by the preterm babies as well as poor neonatal intensive care facilities and drought of specialist to cater for the special needs of these babies. [2] Most of the preterm babies succumb to necrotizing enetrocolitis, sepsis, and respiratory problems. [6, 7] Beyond the neonatal period, survivors have worse neural development, poor school performance, increased risk of cerebral palsy, and metabolic diseases in adulthood. [8] [9] [10] In addition to good neonatal intensive care facilities, the survival of the preterm babies is inversely related to the gestational age at delivery and birth weight. [6, 7, 11] Recently, there is increasing advocacy on the use of antenatal steroid to hasten fetal lung maturity and improve neonatal survival particularly for women that are at risk of delivery before 34 weeks. Administration of corticosteroids to women at risk of PTD produce a considerable reduction in the risks of complications of prematurity such as combined fetal and neonatal death, respiratory distress syndrome, cerebroventricular hemorrhage, necrotizing enterocolitis, systemic infections, and childhood developmental delay. [12, 13] Bethamethasone and dexamethasone have been shown by various workers to reduce perinatal morbidity and mortality for preterm babies. [12, 13] In view of the above evidence, antenatal dexamethasone injections was enshrined in our department protocol for the management of PTD in 2013 but its effectiveness has not been reviewed in our hospital.
The antenatal steroid seems to be a viable option in our setting because of availability and ease of administration; however, this approach is hampered by the difficulty in identifying all women at risk of PTD. [14, 15] In fact, many of the women present to the hospital when delivery is imminent. Other low technology modalities such as training community health workers in Kangaroo Mother Care (KMC), essential newborn care and special care of the moderately preterm baby will go a long way in reducing the perinatal mortality. [16] More so that preterm babies of African descend tend to be more matured at delivery than their Caucasian counterpart and are less likely to develop respiratory distress syndrome or require incubator. [8, 17] Earlier studies reviewed the risk factors for PTD with a view to modifying them and possibly improve the survival of the preterm babies; however, a study by Iyoke et al. in Enugu, Nigeria showed poor correlation between the maternal risk factors for PTD and perinatal survival. [18] Other researchers have found better perinatal survival of the preterm babies with increasing gestational age at delivery, higher birth weights as well as cesarean delivery than vaginal delivery. [2, 19, 20] Knowledge of the factors that determines neonatal survival following PTD is vital in counselling women with preterm labour and also in preparations to optimize the survival for the preterm babies in our settings. To the best of our knowledge, no such study had been done in the North-Eastern Nigeria. We set out to study the determinants of the outcome of preterm births at the UMTH, Maiduguri.
Patients and Methods
A retrospective case-control study of women who had PTD at the … from January 1, 2014 to December 31, 2015 was carried out. The labour ward register, the Special Care Baby Unit (SCBU) register, and case records were used and for each PTD, and the next woman that delivered at term was recruited as control.
For the purpose of this study, PTD is delivery before 37 completed weeks, and gestational age was calculated from early scan or last menstrual period.
Information on sociodemographic characteristics, risk factors for PTD, use of dexamethasone, interval between commencement of dexamethasone and delivery, gestational age at delivery, mode of delivery, indication for delivery, Apgar score, SCBU admission, perinatal mortality, and take home baby rate were collated. The information was coded and transferred onto a profoma designed for the study. This was then transferred onto SPSS version 16 statistical software and analyzed. The socio-demographic characteristics, pregnancy complications, and birth outcomes are presented as percentages on frequency tables. Chi-square test and student's t-test were used to analyze for categorical variables and continuous variables, respectively. Multinomial logistic regression was used for multivariate analysis to construct a model for factors associated with neonatal survival. The statistical significance was set at P < 0.05.
Research and Ethics committee of the … granted approval for the study.
Results
There were 226 preterm deliveries and 43 had incomplete information and were excluded in the analysis. The remaining 183 preterm births (with 195 babies) were compared with 183 term births (with 184 babies). PTD occurred in 10.38% (19/183) of teenage mothers and 31.16% (68/183) of the PTD were before 32 weeks of gestation. Majority of the mothers have had at least basic education (63.69%) as shown in Table 1 .
The mean duration of admission for the preterm babies was 1.9 + 8.4 days with neonatal survival and take home baby rate of 72.31% (141/195). Table 2 showed the factors associated with neonatal survival following PTD. Neonatal survival was significantly associated with delivery at or beyond 32 weeks, pre-labour premature rupture of membranes (PPROM), previous PTD Table 3 .
Discussion
PTD is a multi-faceted process, resulting from the interplay of factors causing the uterus to change from quiescence to active contraction, which leads to delivery before 37 completed weeks of gestation or purposely induced in the interest of the mother, fetus or both, anytime the risk of continuing the pregnancy outweigh the risk of delivery. In any case neonatal survival is an important consideration especially for the couple in guiding their decision.
Our neonatal survival rate of 72.31% after PTD is higher than the 65.5% earlier reported in the same centre by Ambe et al. in 2007 . This improvement can be attributed to the use of antenatal dexamethasone during the period under review in patients at risk of PTD. It is hoped that with the regular use of antenatal corticosteroid we will record better survival in the future. Our neonatal survival higher than the 65.9% recorded in Akure [6] but similar to the 69.9% recorded in Sokoto, [7] Nigeria. Both studies did not report the use of antenatal corticosteroids.
Neonatal survival is said to be rare before the age of 24 weeks and exceeds 90% for preterm infants of more than 29 weeks in the developed countries. [21, 22] However, it is very difficult to assign a cut off weeks for neonatal survival in our environment but our finding showed that babies delivered after 32 weeks are 12 times more likely to survive than babies delivered before then. The improved survival with increasing gestational age at delivery is not surprising because the neonate vital organ's functionality improves progressively with increasing gestational age till 40 weeks in some cases. [23] PPROM is a known risk factor for PTD, and in keeping with our finding a recent study by Tsafrir et al., found a better neonatal outcome in babies born preterm following PPROM compared those delivered without PPROM at the same gestational age. [24] It has been postulated that PPROM puts undue stress on the mother and stressed pregnancies have been associated with accelerated fetal lung maturity due to increased maternal glucocorticoid levels. [25, 26] Hence, the conclusion by Tsafrir et al. that women with PPROM after 32 weeks should be delivered without undue delays in order to reduce the risk of chorioamnionitis. [24] The association of PPROM with neonatal survival should be taken with caution because some studies have found that 25% of PTD are associated with intrauterine infection and the risk is more in cases with PPROM. Gonclaves et al. found positive cultures in 32.4% of PTD complicated by PPROM, which further exposes the neonate to neonatal sepsis that could jeopardize neonatal survival. [27] Other maternal infections including urinary tract infections, malaria, bacterial vaginosis, HIV, and syphilis are all associated with increased risk of preterm birth and poor neonatal outcome. [28] This could explain why peripartum fever was found to be associated with poorer neonatal outcome in our study and most of the febrile mother tested positive for malaria (not shown in the result). A high prevalence of both maternal and placental malaria of 30.7% and 33.9%, respectively, has been observed earlier in the same centre and the placental malaria has been linked to both PTD and low birth weight. [29] We found previous PTD to be associated with better neonatal survival and our finding contrast with that of Whiteman et al. who found previous PTD to be associated with increased risk of neonatal death in subsequent delivery. [30] They argued that the risk of subsequent neonatal death may be because of worsening prematurity in the subsequent pregnancies and it could be a recurrent problem. However, our finding of improved survival may be related to the women seeking for better neonatal care in their subsequent pregnancies particularly in a tertiary health facility where we conducted our study. Certainly, a well equipped SCBU will improve neonatal survival and majority of these facilities in the developing countries are located in the tertiary health centres.
Respiratory distress syndrome (RDS) is a common condition in premature babies that can lead to mortality [6, 7, 11, 31] and a review by Hofmeyr [12] showed that fetal lung maturity can be aided by antenatal corticosteroids leading better neonatal survival. Our study also confirmed this assertion and showed that antenatal dexamethasone is associated independently with neonatal survival. This finding is important for a developing country like ours where SCBU facility like the use of surfactant is either not available or very expensive. Dexamethasone is cheap and readily available and with the above evidence its utilisation can be encouraged even in the primary health care facilities upon diagnoses of impending PTD pending referral to the tertiary centres for delivery.
Furthermore, the benefit of antenatal dexamethasone is seen even in infants born less than 24 hours after administration of the first dose [12, 32] and this was also seen in our study. We found preterm babies delivered 24 hours after commencement of the injections to be five times more likely to survive than those delivered earlier.
Dexamethasone is not without its untoward effect on the neonates as there are reports of hypoglycemia amongst exposed neonates. [13, 32] This calls for vigilance after delivery in order to detect and treat such babies.
Conclusion
The neonatal survival following PTD is 72.31%. Survival is more likely in babies born after 32 weeks, PPROM, and at least 24 hours after antenatal dexamethasone injections. Maternal febrile illness and polyhydramnios threatened neonatal survival. We recommend routine use of dexamethasone in pregnancies at risk of PTD and planned delivery at the tertiary centre with equipments to cater for the special needs of the preterm babies.
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